Send the following on WhatsApp
Continue to ChatEuropean Commission approves Dupixent as first and only targeted prurigo nodularis medicine on Labiotech.eu https://www.labiotech.eu/trends-news/ec-approves-dupixent-first-only-targeted-prurigo-nodularis-medicine/